Ionis Pharmaceuticals Archives -

NICE relents and okays Akcea’s rare disease drug Waylivra for NHS use

https://pharmaphorum.com/news/nice-relents-and-okays-akceas-rare-disease-drug-waylivra-for-nhs-use/

GSK takes option to license hepatitis B RNA drugs from Ionis

https://pharmaphorum.com/news/gsk-takes-option-to-license-hepatitis-b-rna-drugs-from-ionis/

Ionis’ FCS drug approved in EU, launch due in Germany

https://pharmaphorum.com/news/ionis-fcs-drug-approved-in-eu-launch-due-in-germany/

Ionis and Roche to develop RNAi AMD drug in $760m deal

https://pharmaphorum.com/news/ionis-and-roche-to-develop-rnai-amd-drug-in-760m-deal/

FDA approves Ionis/Akcea’s Tegsedi RNAi drug, taking on Alnylam

https://pharmaphorum.com/news/fda-approves-ionis-akceas-tegsedi-competing-against-alnylam/

US regulators reject Akcea and Ionis rare disease drug

https://pharmaphorum.com/news/us-regulators-reject-akcea-ionis-rare-disease-drug/

AZ grabs licence as Ionis NASH drug heads to the clinic

https://pharmaphorum.com/news/az-grabs-licence-ionis-nash-drug-heads-clinic/

AZ signs kidney drug deal with Ionis for up to $330m

https://pharmaphorum.com/news/az-buys-kidney-disease-drug-from-ionis-for-up-to-330m/

Roche takes on development of potential Huntington’s breakthrough

https://pharmaphorum.com/news/roche-takes-development-potential-huntingtons-breakthrough/

Search